CountryFocus: Healthcare, Regulatory and

Reimbursement Landscape - Indonesia

Channel sales partner

Indonesias Pharmaceutical Market will Continue Rapid Growth to $12.6 Billion by

2020
Pharmaceutical Market, Indonesia, Revenue ($bn), 20082020
14

12

Revenue ($bn)

10

0
2008

2014

2017

2020

Source: IPMG, 2014. Sudharta et al., 2010

The pharmaceutical market in Indonesia more than doubled from just under $3
billion in 2008 to reach approximately $7 billion in 2015 and is anticipated to
increase further to $12.6 billion by 2020, driven primarily by the Indonesian
governments economic and healthcare initiatives. Indonesias pharmaceutical
sector will be boosted by the establishment of a universal healthcare scheme,
known as the Jaminan Kesehatan Nasional. This was launched in January 2014 with
the aim of providing health insurance to 250 million Indonesian citizens by 2019,
which would make it the worlds largest social health insurance. New economic
policy packages, the high prevalence of infectious diseases, widespread generic drug
supply, increasing affordability of healthcare products and the large over-thecounter medicines market will also help to drive growth in Indonesias
pharmaceutical sector.

click to purchase - http://www.aarkstore.com/healthcare/188210/countryfocus-healthcare-regulatory-and-reimbursement-landscape-indonesia

GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.